Literature DB >> 19963332

Assessing the impact of a modified informed consent process in a South African HIV/AIDS research trial.

Claire Penn1, Melanie Evans.   

Abstract

OBJECTIVE: The process of informed consent may be jeopardized in cross-linguistic research trials but little is known about the factors which contribute to this. The present study was designed to assess the impact on the understanding of trial participants of the essential components of a trial, as well as on the perceptions of the participants, through enrollment via a standard versus a modified informed consent protocol.
METHODS: Counselors from two HIV trial sites in South Africa were trained to enroll patients for a trial, using a modified informed consent protocol. The standard and modified protocols were compared.
RESULTS: Marked differences were noted in effectiveness of the process after training using the modified protocol, resulting in improved patient understanding. An item analysis suggested those areas of the trial which were most difficult for counselors to communicate effectively and highlighted potential barriers and facilitators to the process.
CONCLUSIONS: Cultural and linguistic modifications to the informed consent process can enhance the understanding of components of a research trial and are viewed as largely positive by the participants. PRACTICE IMPLICATIONS: Some implications for future enrollments, for developing policy and for the role of a language specialist on research ethics committees and in trial design are highlighted. Copyright 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19963332     DOI: 10.1016/j.pec.2009.10.019

Source DB:  PubMed          Journal:  Patient Educ Couns        ISSN: 0738-3991


  8 in total

1.  Tailoring information provision and consent processes to research contexts: the value of rapid assessments.

Authors:  Susan Bull; Bobbie Farsides; Fasil Tekola Ayele
Journal:  J Empir Res Hum Res Ethics       Date:  2012-02       Impact factor: 1.742

2.  Consent and community engagement in diverse research contexts.

Authors: 
Journal:  J Empir Res Hum Res Ethics       Date:  2013-10       Impact factor: 1.742

3.  I'm positive, but i'm negative: Competing Voices in Informed Consent and Implications for HIV vaccine trials.

Authors:  Clinton Rautenbach; Graham Lindegger; Catherine Slack; Melissa Wallace; Peter Newman
Journal:  J Empir Res Hum Res Ethics       Date:  2015-04       Impact factor: 1.742

4.  Cluster randomized trial assessing the effects of rapid ethical assessment on informed consent comprehension in a low-resource setting.

Authors:  Adamu Addissie; Serebe Abay; Yeweyenhareg Feleke; Melanie Newport; Bobbie Farsides; Gail Davey
Journal:  BMC Med Ethics       Date:  2016-07-12       Impact factor: 2.652

5.  Bioethical reflexivity and requirements of valid consent: conceptual tools.

Authors:  John Barugahare
Journal:  BMC Med Ethics       Date:  2019-07-04       Impact factor: 2.652

6.  Linguistic and Cultural Challenges in Communication and Translation in US-Sponsored HIV Prevention Research in Emerging Economies.

Authors:  Donna Hanrahan; Patrina Sexton; Katrina Hui; Jennifer Teitcher; Jeremy Sugarman; Alex John London; Mark Barnes; James Purpura; Robert Klitzman
Journal:  PLoS One       Date:  2015-07-30       Impact factor: 3.240

7.  Lost in translation: assessing effectiveness of focus group questioning techniques to develop improved translation of terminology used in HIV prevention clinical trials.

Authors:  Natasha Mack; Catalina B Ramirez; Barbara Friedland; Soori Nnko
Journal:  PLoS One       Date:  2013-09-10       Impact factor: 3.240

8.  Digitised audio questionnaire for assessment of informed consent comprehension in a low-literacy African research population: development and psychometric evaluation.

Authors:  Muhammed O Afolabi; Kalifa Bojang; Umberto D'Alessandro; Martin O C Ota; Egeruan B Imoukhuede; Raffaella Ravinetto; Heidi J Larson; Nuala McGrath; Daniel Chandramohan
Journal:  BMJ Open       Date:  2014-06-24       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.